Shanghai Junshi Biosciences has started an early-stage study in China to test a potential antibody treatment against the coronavirus in uninfected people, official paper Liberation Daily said on its ... ( read original story ...)
Shanghai’s logistics industry revels in chaotic boom as rates soar, ‘dreads’ the arrival of coronavirus vaccine
Chen Monian was transporting cartons of personal protective equipment (PPE) from a container truck to a cargo terminal at the Pudong International Airport when the watch showed it was time to clock ... ( read original story ...)
Week In Review: China Life Science Companies Raise Nearly $1 Billion Led By Legend’s $424 Million U.S. IPO
Legend Biotech priced its US IPO above the expected range at $23 per ADS, raising $424 million. Jacobio Pharma out-licensed rights for its two-molecule SHP2 pro ... ( read original story ...)
BRIEF-Sinocelltech Sets Pricing For Shanghai IPO
SINOCELLTECH GROUP SAYS IT AIMS TO RAISE UP TO 1.28 BILLION YUAN ($180.77 million) AT 25.64 YUAN PER SHARE IN INITIAL SHARE PUBLIC OFFERING AT SHANGHAI STAR BOARD Source text in Chinese: ... ( read original story ...)
Shanghai’s logistics industry revels in chaotic boom as rates soar, ‘dreads’ the arrival of Covid-19 vaccine
The coronavirus pandemic foments a fourfold jump in air freight rates and a US$17.7 billion rally in a medical ventilator company. Shanghai’s logistics industry is revelling in the chaotic boom. ( read original story ...)
IPO and M&A activities remain active despite COVID-19 epidemic
While global capital markets have been hit by the COVID-19 pandemic, Chinese bourses have shown resilience by reporting stable initial public offering activity and a strong forecast for mergers and ... ( read original story ...)
Real Time Engagement API Provider Agora Announces Filing for IPO under the ticker symbol “API”
Agora, Inc. today announced that it has filed a registration statement on Form F-1 with the Securities and Exchange Commission relating to ... ( read original story ...)